Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Actelion Ltd    ATLN   CH0010532478

ACTELION LTD (ATLN)

47
Delayed Quote. Delayed BATS EUROPE - 02/27 05:28:44 pm
114.1000 CHF   0.00%
02/16 ACTELION : Q4 Core Net Income Down
02/16 ACTELION : to discuss full year 2014 financial results
02/16 ACTELION : delivers outstanding 2014 results
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Actelion Ltd
Develops, produces and markets pharmaceutical drugs

Actelion Ltd. operates as a holding company with interests in developing, producing and marketing pharmaceutical drugs.

It is a biopharmaceutical company, which focuses on the drug discovery, development, registration, production and commercialization of innovative drugs for diseases with significant unmet medical needs.

The company's portfolio of PAH treatments covers the spectrum of disease, from WHO Functional Class (FC) II through to FC IV, with oral, inhaled and intravenous medications.

It has treatments for specialist diseases, including Type 1 Gaucher disease, Niemann-Pick type C disease, digital ulcers in patients suffering from systemic sclerosis and mycosis fungoides in patients with cutaneous T-cell lymphoma.

The company products include Tracleer (bosentan), Zavesca (miglustat), Ventavis (iloprost), Veletri (epoprostenol for injection), Valchlor and Opsumit (macitentan).

Actelion was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Mueller, and Thomas Widmann on December 17, 1997 and is headquartered in Allschwil, Switzerland.
Sales per Businesses
20122013Delta
CHF (in Million)%CHF (in Million)%
Drugs1,728100%1,786100% +3.21%
Sales per Regions
20122013Delta
CHF (in Million)%CHF (in Million)%
United States709.6541.1%767.9643% +7.59%
Europe616.9635.7%632.0635.4% +2.39%
Rest of the World368.8121.3%356.6620% -3.41%
Switzerland32.981.9%29.061.6% -13.52%
Managers
NameAgeSinceTitle
Jean-Paul Clozel591997Chief Executive Officer & Executive Director
Jean-Pierre Garnier672011Chairman
Otto Schwarz592008Chief Operating Officer & Executive Vice President
André C. Muller, MBA512013Chief Financial Officer & Executive Vice President
Martine Clozel, MD591997Chief Scientific Officer & Senior Vice President
Guy Braunstein MD, PhD582009Executive VP & Head-Global Clinical Development
Michael Jacobi, PhD612009Non-Executive Director
Werner Henrich71-Non-Executive Director
Jean Pierre Malo CFA, MBA60-Non-Executive Director
Juhani Anttila60-Non-Executive Director
Shareholders
NameShares%
BlackRock Investment Management (UK) Ltd. 6,169,763 5.41%
Rudolf Maag, MBA 6,067,305 5.32%
Jean-Paul Clozel, MD 5,281,544 4.63%
Orbis Investment Management Ltd. 3,568,489 3.13%
Fidelity Management & Research Co. 3,169,026 2.78%
Actelion Ltd. 2,997,797 2.63%
Wellington Management Co. LLP 2,545,698 2.23%
Bellevue Asset Management AG 2,400,712 2.10%
Norges Bank Investment Management 2,310,020 2.02%
Artisan Partners LP 2,255,055 1.98%
Holdings
NameShares%Valuation
Actelion Ltd (ATLN) 2,997,7972.63%357,495,476 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
ACTELION LTD
SHANGHAI RAAS BLO..
-
MEDIVATION INC
INTERCEPT PHARMAC..
GENMAB A/S
AGIOS PHARMACEUTI..
RECEPTOS INC
HUALAN BIOLOGICAL..
NEUROCRINE BIOSCI..
BLUEBIRD BIO INC
BEIJING SL PHARMA..
TONGHUA DONGBAO P..
MANNKIND CORPORAT..
CLOVIS ONCOLOGY I..
PTC THERAPEUTICS,..
INSYS THERAPEUTIC..
DYAX CORP.
AUSPEX PHARMACEUT..
-
TESARO INC
HALOZYME THERAPEU..
Sector Biotechnology & Medical Research
Company contact information
16 Gewerbestrasse
CH-4123 Allschwil, Basel-Landschaft
Switzerland

Phone : +41 61 565 65 65
Fax : +41 61 565 65 00
Internet : http://www.actelion.com
Markets and indexes
- SIX Swiss Exchange
- Main Standard
- SMI /
Stock Exchange Codes
- ISIN Code :  CH0010532478
- Bloomberg Code :  ATLN:VX
- Reuters Code :  ATLN.VX
- Datastream Code :  S:ATLN
© 2015 Factset    © 2015 Cofisem   
Dynamic quotes  
ON
| OFF